ciprofloxacin has been researched along with Malaria in 12 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized, open study of high-dose ciprofloxacin (750 mg every 12 h) in uncomplicated falciparum malaria was conducted in Thailand." | 9.07 | Ciprofloxacin treatment of drug-resistant falciparum malaria. ( Edstein, MD; Pavanand, K; Shanks, GD; Watt, G; Webster, HK; Wechgritaya, S, 1991) |
| "We investigated the in vivo antimalarial activities of pefloxacin and ciprofloxacin in Swiss albino mice infected intravenously with 5 x 10(6) Plasmodium yoelii N67 parasites 1 h before treatment." | 7.68 | Activities of pefloxacin and ciprofloxacin against experimental malaria in mice. ( Deloron, P; Gaudin, C; Lebras, J; Malhotra, K; Pocidalo, JJ; Salmon, D, 1990) |
| "A randomized, open study of high-dose ciprofloxacin (750 mg every 12 h) in uncomplicated falciparum malaria was conducted in Thailand." | 5.07 | Ciprofloxacin treatment of drug-resistant falciparum malaria. ( Edstein, MD; Pavanand, K; Shanks, GD; Watt, G; Webster, HK; Wechgritaya, S, 1991) |
| "The increasing spread of chloroquine resistant malaria has intensified the search for new antimalarial treatment, especially drugs that can be used in combination." | 3.78 | Interaction between ciprofloxacin and chloroquine in mice infected with chloroquine resistant Plasmodium berghei: interaction between ciprofloxacin and chloroqune. ( Abiodun, OO; Gbotosho, GO; Happi, CT; Oduola, AM; Sowunmi, A; Woranola, O, 2012) |
| "The antimalarial activity of combinations of mefloquine or artesunic acid with ciprofloxacin and other synthetic fluoroquinolone was tested in vitro against Plasmodium falciparum using a strain (BHz26/86) partially resistant to chloroquine and a resistant clone (W2); both are sensitive to mefloquine." | 3.74 | Enhanced activity of mefloquine and artesunic acid against Plasmodium falciparum in vitro and P. berghei in mice by combination with ciprofloxacin. ( Andrade, AA; Boechat, N; de Freitas, IO; de Pilla Varotti, F; de Souza, MV; Krettli, AU; Vasconcelos, TR, 2007) |
| "We investigated the in vivo antimalarial activities of pefloxacin and ciprofloxacin in Swiss albino mice infected intravenously with 5 x 10(6) Plasmodium yoelii N67 parasites 1 h before treatment." | 3.68 | Activities of pefloxacin and ciprofloxacin against experimental malaria in mice. ( Deloron, P; Gaudin, C; Lebras, J; Malhotra, K; Pocidalo, JJ; Salmon, D, 1990) |
| "Typhoid fever is an acute infectious disease caused by Salmonella serotype Typhi, leading to endemic or epidemic outbreaks in tropical/ subtropical countries (especially in India, Southeast Asia, Central and South Africa)." | 1.33 | [A case with fever of unknown origin during treatment for malaria: multi-drug resistant Salmonella typhi infection]. ( Akin, K; Cesur, S; Esen, B; Levent, B; Willke, A; Yavuzdemir, S, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amorha, KC | 1 |
| Ugwuowo, OB | 1 |
| Ayogu, EE | 1 |
| Nduka, SO | 1 |
| Okonta, MJ | 1 |
| Levine, AC | 1 |
| Shetty, PP | 1 |
| Henwood, PC | 1 |
| Sabeti, P | 1 |
| Katz, JT | 1 |
| Vaidya, A | 1 |
| Falajiki, YF | 1 |
| Akinola, O | 1 |
| Abiodun, OO | 2 |
| Happi, CT | 2 |
| Sowunmi, A | 2 |
| Gbotosho, GO | 2 |
| Woranola, O | 1 |
| Oduola, AM | 1 |
| Akin, K | 1 |
| Yavuzdemir, S | 1 |
| Cesur, S | 1 |
| Levent, B | 1 |
| Esen, B | 1 |
| Willke, A | 1 |
| Andrade, AA | 1 |
| de Pilla Varotti, F | 1 |
| de Freitas, IO | 1 |
| de Souza, MV | 1 |
| Vasconcelos, TR | 1 |
| Boechat, N | 1 |
| Krettli, AU | 1 |
| López-Vélez, R | 1 |
| Sánchez Mancilla, R | 1 |
| García Camacho, A | 1 |
| Salmon, D | 1 |
| Deloron, P | 1 |
| Gaudin, C | 1 |
| Malhotra, K | 1 |
| Lebras, J | 1 |
| Pocidalo, JJ | 1 |
| Watt, G | 1 |
| Shanks, GD | 1 |
| Edstein, MD | 1 |
| Pavanand, K | 1 |
| Webster, HK | 1 |
| Wechgritaya, S | 1 |
| Krishna, S | 1 |
| Davis, TM | 1 |
| Chan, PC | 1 |
| Wells, RA | 1 |
| Robson, KJ | 1 |
1 trial available for ciprofloxacin and Malaria
| Article | Year |
|---|---|
Ciprofloxacin treatment of drug-resistant falciparum malaria.
Topics: Adult; Animals; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance; Humans; Malaria; M | 1991 |
11 other studies available for ciprofloxacin and Malaria
| Article | Year |
|---|---|
Evaluation of the hepatic effect of concomitant administration of ciprofloxacin and some antimalarial drugs in Plasmodium berghei infected mice: An in vivo study.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Chemical and Drug Induced Liver Injury; Ciprofloxacin | 2018 |
Interactive medical case. A Liberian health care worker with fever.
Topics: Anti-Bacterial Agents; Antibodies, Viral; Ciprofloxacin; Combined Modality Therapy; Diagnosis, Diffe | 2015 |
Amodiaquine-Ciprofloxacin: a potential combination therapy against drug resistant malaria.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Ciprofloxacin; Dose-Response Relationship, Drug; D | 2015 |
Interaction between ciprofloxacin and chloroquine in mice infected with chloroquine resistant Plasmodium berghei: interaction between ciprofloxacin and chloroqune.
Topics: Animals; Antimalarials; Chloroquine; Ciprofloxacin; Disease Models, Animal; Drug Resistance; Drug Th | 2012 |
[A case with fever of unknown origin during treatment for malaria: multi-drug resistant Salmonella typhi infection].
Topics: Adult; Afghanistan; Agglutination Tests; Anti-Infective Agents; Antibodies, Bacterial; Ciprofloxacin | 2005 |
Enhanced activity of mefloquine and artesunic acid against Plasmodium falciparum in vitro and P. berghei in mice by combination with ciprofloxacin.
Topics: Animals; Antimalarials; Artemisinins; Ciprofloxacin; Drug Synergism; Malaria; Mefloquine; Mice; Para | 2007 |
Fluoroquinolone antimicrobials.
Topics: Adult; Animals; Anti-Infective Agents; Antimalarials; Ciprofloxacin; Democratic Republic of the Cong | 1995 |
Advice for travelers.
Topics: Anti-Infective Agents; Antidiarrheals; Bacterial Vaccines; Cholera; Ciprofloxacin; Diarrhea; Diphthe | 1998 |
Advice for travelers.
Topics: Africa; Altitude Sickness; Asia; Chloroquine; Ciprofloxacin; Contraindications; Diarrhea; Female; He | 2002 |
Activities of pefloxacin and ciprofloxacin against experimental malaria in mice.
Topics: Animals; Ciprofloxacin; Female; Malaria; Mice; Pefloxacin; Plasmodium yoelii; Staining and Labeling | 1990 |
Ciprofloxacin and malaria.
Topics: Animals; Ciprofloxacin; Humans; Malaria; Plasmodium falciparum; Time Factors | 1988 |